Meng Tan, MD
University of Michigan, Ann Arbor, Michigan
Dr. Tan graduated with his MD (cum laude) from Dalhousie University, Halifax, Canada. After his internal medicine residency there, he completed post-doctoral training in diabetes at the Joslin Diabetes Center, Harvard University, Boston, and in lipoprotein metabolism at the Cardiovascular Research Institute, University of California, San Francisco.
He returned to his alma mater for over 2 decades and was active in clinical practice, research (basic and clinical), education, and administration. When he left Dalhousie in 1996, he was Professor of Medicine and Biochemistry and Associate Professor of Community Health and Epidemiology. He was Head of Dalhousie’s Division of Endocrinology and Metabolism and Deputy Head of Dalhousie’s Department of Medicine as well as Head of the Department of Medicine at one of the adult teaching hospitals.
He then spent a decade in the private sector – initially as Medical Director, Diabetes Disease Management at Becton-Dickinson, Franklin Lakes, and then as Senior Global Medical Director for Diabetes as well as Distinguished Medical Fellow in Eli Lilly and Company and Lilly Research Laboratory, Indianapolis.
In 2008, he joined University of Michigan in Ann Arbor as Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes. He is the inaugural editor of Clinical Diabetes and Endocrinology. He is currently Professor Emeritus (Active) there.
He has about 200 peer-reviewed publications on diabetes, dyslipidemias, endocrinology, and metabolism. He is a past President of the Canadian Diabetes Association, Chair of the Canadian Diabetes Advisory Board, and Vice-President of the International Diabetes Federation.